* Prophase Labs Inc PRPH.OQ PRPH.O is expected to report
results on August 13.
* The New York City, New York-based company is expected to
report revenue of $15.651 million, according to the mean
estimate from 2 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prophase Labs Inc is
for earnings of 34 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Prophase Labs
Inc is $22.5, about 65.9% above its last closing price
of $7.67.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.20 0.21 0.27 Beat 31.7
Dec. 31 2020 -0.02 -0.02 -0.23 Missed -1,050
This summary was machine generated August 11 at 12:49 GMT. All
figures in US dollars unless otherwise stated